Biological correlation between HER-2/neu and proliferative activity in human breast cancer
- PMID: 1684096
Biological correlation between HER-2/neu and proliferative activity in human breast cancer
Abstract
HER-2neu alterations (amplification and overexpression), proliferative activity (3H-Thymidine-Labeling Index, 3H-Tdr-LI) and tumor ploidy (flow-cytometry) were analyzed in a human breast cancer series. Overexpressed tumors showed a significantly higher median 3H-Tdr-LI than normally expressed (p = 0.04), as also did amplified/overexpressed with respect to non-amplified/normally expressed (p less than 0.04). These differences were confirmed only in N-primary tumors. In fact, high expressed cases demonstrated a median 3H-Tdr-LI of 5.5% with respect to 1.9% for low expressed cases (p = 0.04) and amplified/overexpressed had a 3H-Tdr-LI of 9% with respect to 2% for non amplified/low expressed (p = 0.009). HER-2/neu alterations were not correlated with tumor DNA content.
Similar articles
-
Comparative long-term prognostic value of quantitative HER-2/neu protein expression, DNA ploidy, and morphometric and clinical features in paraffin-embedded invasive breast cancer.Lab Invest. 1991 Feb;64(2):215-23. Lab Invest. 1991. PMID: 1671789
-
HER-2/neu amplification predicts poor survival in node-positive breast cancer.Cancer Res. 1990 Jul 15;50(14):4332-7. Cancer Res. 1990. PMID: 1973070
-
Her-2/neu oncogene expression in Puerto Rican females with breast cancer.Cell Mol Biol (Noisy-le-grand). 2001 Sep;47(6):1025-32. Cell Mol Biol (Noisy-le-grand). 2001. PMID: 11785652
-
Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.APMIS Suppl. 2003;(108):1-67. APMIS Suppl. 2003. PMID: 12874968 Review.
-
Steroid receptors and other prognostic factors in primary breast cancer.Semin Oncol. 1988 Apr;15(2 Suppl 1):20-5. Semin Oncol. 1988. PMID: 3285482 Review.
Cited by
-
A Retrospective Analysis of Precision Medicine Outcomes in Patients With Advanced Cancer Reveals Improved Progression-Free Survival Without Increased Health Care Costs.J Oncol Pract. 2017 Feb;13(2):e108-e119. doi: 10.1200/JOP.2016.011486. Epub 2016 Oct 31. J Oncol Pract. 2017. PMID: 27601506 Free PMC article.
-
ErbB-2 oncoprotein overexpression in breast carcinoma: inverse correlation with biochemically- and immunohistochemically-determined hormone receptors.Breast Cancer Res Treat. 1995 Aug;35(2):201-10. doi: 10.1007/BF00668210. Breast Cancer Res Treat. 1995. PMID: 7647342
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Research Materials
Miscellaneous